MedTrace Logo

Human Partial Facial Allotransplantation

NCT00663988 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2008-04-22

No results posted yet for this study

Summary

Progress in composite tissue allotransplantation provides a new remedy for severely disfigured patients. We plan to carry out allograft composite tissue transplantation after a careful systemic preparation.

Conditions

  • Pharmaceutical Preparations

Interventions

PROCEDURE

human transplantation

Allograft composite tissue transplantation. procedure. medication

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Shuzhong Guo, Dr · Xijing Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00663988 on ClinicalTrials.gov